Clinical Trial Update: Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) [Phase 2]

View source ↗

Summary

The update concerns a Phase 2 trial of SUN N4057 for acute ischemic stroke with MRI-identified penumbra that has been terminated. The sponsor listed is Daiichi …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SUN N4057

Snippet

Sponsor: Daiichi Sankyo | Conditions: Stroke | Phase 2 | Status: TERMINATED